BlackBio (Group)

https://www.blackbio.eu

Twitter: @blackbio_eu

Founded in 2009, BlackBio is positioned as a leader in the fields of personalized medicine, medical diagnostics and pharmacogenomics by providing solutions through high-sensitive microsequencing, focusing its developments in the areas of metabolism, oncology, cardiovascular and microbiology. BlackBio, has started its activity in the Spanish market with a medium term objective to become a company with strong international presence and a solid product portfolio. By 2015, BlackBio estimates to reach annual sales of 20 million euros (75% in the international market). *

	Start	2009-01-01 established
	Today	2B BlackBio S.L.
	Industry	pharmacogenomics/pharmacogenetics
	Industry 2	BIOTECH

	Region	Madrid
	Country	Spain (España)
	Street	7 C/ Faraday Parque Cientifico de Madrid, 2° planta (Cantoblanco)
	City	28049 Madrid
	Tel	+34-91-7961300
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: 2B BlackBio S.L.. (10/25/11). "Press Release: BlackBio Gets more than 2 Million Euros after Capital Increase and Public Funding".

		Record changed: 2018-09-12

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for BlackBio (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]